Astragalus caraganae
Astragalus caraganae · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Astragalus caraganae is a significant medicinal plant known for its diverse pharmacological properties and therapeutic potential. To enhance the delivery and efficacy of its bioactive compounds, researchers focus on developing advanced delivery systems. One promising approach involves the creation of an extract tailored for improved bioavailability. Specifically, the development of a nanoformulation using nanostructured lipid carriers (AP-NLCs) offers a sophisticated method for stabilizing these sensitive constituents. This technological integration aims to optimize the medicinal performance of Astragalus caraganae through precise nanotechnology.
- Synonyms
- Astragalus Warackensis · Astragalus Nachitschevanicus · 3 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Common Names
Astragalus caraganae is a distinctive plant species known by its common name, Астрагал караганниковый. This hardy legume plays a vital role in its native ecosystems by helping to stabilize soil and enrich the ground with nitrogen. Its unique physiological traits allow it to thrive in specific environmental niches where other vegetation might struggle. Botanists often study its growth patterns to better understand the complex biodiversity of its natural habitat. Through its resilient nature, this plant remains a significant subject of interest for both ecologists and local residents alike.
Sources: Catalogue of Life (COL)
Synonyms
Astragalus caraganae is a taxonomically complex species that is associated with several different scientific names. Throughout botanical literature, it has been identified by various synonyms, including Astragalus borudjerdicus and Astragalus nachitschevanicus. The plant is also recognized under the name Astragalus warackensis, reflecting different historical classifications. Further variations include the specific designation of Astragalus caraganae var. brevicalyx within certain studies. Additionally, the name Tragacantha caraganae serves as another formal synonym used to describe this particular organism.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Astragalus caraganae is a specialized member of the kingdom Plantae. Within this vast biological realm, it is classified under the class Equisetopsida. It belongs to the order Fabales, which places it in a specific evolutionary lineage. Further refinement shows that this species is part of the diverse family Fabaceae. Ultimately, it is identified by its specific genus, Astragalus.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Astragalus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Astragalus caraganae is a resilient species with a broad geographical presence throughout the Asia-Temperate region. Its natural distribution extends across the rugged landscapes of the Caucasus and the Transcaucasus. Furthermore, this plant is commonly found within the diverse ecosystems of Western Asia. Specifically, it thrives in the unique environments of Iran and the country of Türkiye. These varied locations highlight the wide ecological range inhabited by this particular legume.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Astragalus caraganae is characterized by its distinctive growth form as a low-growing herb. This species typically maintains a modest stature, with heights ranging from a minimum of 0.15 m up to a maximum of 0.42 m. Such compact dimensions allow the plant to thrive within its specific ecological niche.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Astragalus caraganae, specifically identified in the research as Astragalus peregrinus, demonstrates a significant potential to treat brain ageing. By utilizing both crude extracts and advanced nanoformulations, the plant helps to alleviate the cognitive impairment associated with aging processes. The study highlights that these extracts effectively treat D-galactose-induced brain ageing in rat models. This therapeutic effect is characterized by the regression of neurodegenerative features and the enhancement of overall brain function. Ultimately, the plant's ability to promote histopathological recovery supports its use in managing the effects of brain ageing.
Preparations
Astragalus caraganae is prepared as an extract to facilitate phytochemical profiling and evaluate antioxidant activities. This plant is also prepared as a nanoformulation, specifically referred to as AP-NLCs, to enhance bioavailability and target drug delivery. Furthermore, the species is prepared as a nanostructured lipid carrier to improve its therapeutic potential. These different preparations allow for the study of cognitive enhancement and the treatment of neurodegenerative features. Through these specific formulations, the plant's ability to promote histopathological recovery and brain function can be effectively investigated.